We design and implement a variety of research projects - from national household surveys to discrete and focused programme reviews or process evaluations. Our researchers have decades of experience in quantitative and qualitative research methodologies, and of applying these in a practical way, which ensures that our findings can be confidently used by the commissioning companies and organisations.
We work with clients on the design of appropriate evaluations for their programmes, using robust methods and a cost-effective approach. We also work with clients to develop user-friendly M&E frameworks and plans, and find ways to represent routinely collected data to encourage better decision making.
Tools to measure success of global bilharzia treatment programme
Merck contracted Genesis to develop programme key performance indicators (KPIs) and an M&E framework to efficiently monitor correct tablet distribution and use at country and community levels of its anti-bilharzia drug Praziquantel (PZQ). Merck has provided nearly one billion PZQ tablets to the World Health Organisation (WHO), which then distributes these to countries for mass drug administration in endemic areas.
Evaluating NHI Phase 1 pilot implementation for Department of Health
Genesis undertook the evaluation of the Phase 1 implementation of the government’s policy of National Health Insurance (NHI) in South Africa. The main aim was to assess whether the NHI Phase 1 interventions had achieved their objective of health system strengthening in primary health care facilities.
Sexual and reproductive services will improve health of SA's youth
Genesis Analytics supported the Department of Basic Education (DBE) to investigate the understanding, accessibility and acceptability of providing sexual and reproductive health (SRH) services to boys and girls attending school in South Africa.
SA cities sign up to meet 90-90-90 targets
UNAIDS contracted Genesis to support the meeting of 19 South African municipalities to implement its 90-90-90 project that assists countries to control the HIV epidemic by setting ambitious targets to get people on antiretroviral (ARV) treatment and ensure they are virally suppressed.